A novel, low-profile filter-wire (Interceptor) embolic protection device during saphenous vein graft stenting - 21/08/11
Doi : 10.1016/j.amjcard.2004.10.023
John J. Young, MD a, ⁎ 
, Dean J. Kereiakes, MD a, A.C. Rabinowitz, MD b, Richard Ammar, MD c, Fred L. Boucher, MSc d, Campbell Rogers, MD e
, Dean J. Kereiakes, MD a, A.C. Rabinowitz, MD b, Richard Ammar, MD c, Fred L. Boucher, MSc d, Campbell Rogers, MD e a The Lindner Center for Research & Education and The Ohio Heart Health Center, Cincinnati, Ohio
b Methodist Hospital, San Antonio, Texas
c St. Johns Hospital, Springfield, Illinois
d Medtronic Vascular, Inc., Danvers, Massachusetts
e Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts
*Dr. Young's address is: The Lindner Center for Research & Education, 2123 Auburn Avenue, Suite 424, Cincinnati, Ohio 45219
Résumé |
A novel, low-profile filter embolic protection device was deployed in 26 patients who underwent stent deployment for saphenous vein graft stenoses in a multicenter trial. Major adverse cardiovascular events were observed in only 2 patients (7.7%) and angiographic flow grades were improved.
Le texte complet de cet article est disponible en PDF.© 2005
Excerpta Medica Inc. Tous droits réservés.
Vol 95 - N° 4
P. 511-514 - février 2005 Retour au numéro
Article précédent
- Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting
- Stéphane Silberman, Catherine Neukirch-Stoop, Philippe Gabriel Steg
- Urinary 8-Hydroxy-2′-Deoxyguanosine levels increase after reperfusion in acute myocardial infarction and may predict subsequent cardiac events
- Yasuhiro Nagayoshi, Hiroaki Kawano, Jun Hokamaki, Shinzo Miyamoto, Sunao Kojima, Hideki Shimomura, Kenichi Tsujita, Tomohiro Sakamoto, Michihiro Yoshimura, Hisao Ogawa
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?